Police seize hepatitis B vaccines in Guinea-Bissau investigation
Authorities raided the Bandim Health Project facilities as part of an investigation into a controversial clinical trial involving newborns.

Police in Guinea-Bissau seized doses of hepatitis B vaccine during a search of the Bandim Health Project facilities on Monday. The judicial police said the operation aimed at clarifying the circumstances related to the batch of vaccines.
The raid involves researchers at the center of a dispute over a study on African newborns. The Bandim Health Project is led by epidemiologist Christine Stabell Benn and anthropologist Peter Aaby. The study received $1.6 million from the US Centers for Disease Control and Prevention (CDC), with an additional $1.6 million matched by the Pershing Square Foundation and the Bluebell Foundation.
The trial design has faced criticism because it would deny hepatitis B vaccines to 7,000 newborns in the first six weeks of life. In Guinea-Bissau, about one in five adults has the virus, and hepatitis B can cause cancer and liver failure. Tarik Jašarević, a spokesperson for the World Health Organization (WHO), said any study denying the vaccine to participants is unethical and exposes newborns to serious harm.
Quinhin Nantote, the health minister of Guinea-Bissau’s transitional government, disputed reports that the trial would move forward. Nantote told the Guardian on Thursday that such reports are not even remotely true. While the Bandim Health Project recently posted a letter of approval from Guinea-Bissau’s national ethics committee dated 14 July, officials have not signed off on the trial.
The researchers previously revised the protocol in August to provide pregnant mothers with more screening for hepatitis B. Christine Stabell Benn said that ethics committees can weigh risks, benefits, and scientific value differently. The Bandim organization is currently fundraising to help roll out vaccines at birth to all newborns in the country.
Key facts
- Police seized a batch of hepatitis B vaccines from the Bandim Health Project in Bissau on Monday.
- The controversial study involves $3.2 million in total funding from the CDC, the Pershing Square Foundation, and the Bluebell Foundation.
- The trial design would have denied the hepatitis B vaccine to 7,000 newborns during their first six weeks of life.
Three perspectives
Neutral
Police conducted a search operation at the Bandim Health Project to clarify circumstances regarding a batch of seized hepatitis B vaccines.
Positive
The Bandim organization is fundraising to help roll out vaccines at birth to all newborns in the country.
Negative
The trial design would potentially expose 7,000 newborns to hepatitis B, risking lifelong infection, cirrhosis, and cancer.
Your week in news, every Wednesday
The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.